奧園美谷(000615.SZ):廣州奧美產業投資擬向民生銀行廣州分行申請4.18億元併購貸款
格隆匯6月8日丨奧園美谷(000615.SZ)公佈,公司第十屆董事會第十五次會議決議,審議通過了《關於控股公司向銀行申請併購貸款及提供擔保的議案》。
公司控股公司廣州奧美產業投資有限公司擬向中國民生銀行股份有限公司廣州分行申請4.18億元的併購貸款,用於浙江連天美企業管理有限公司55%股權收購事宜。公司對上述併購貸款提供不可撤銷連帶責任保證,同時廣州奧美產業投資有限公司以其持有的浙江連天美企業管理有限公司55%股權向中國民生銀行股份有限公司廣州分行提供質押擔保。
該議案尚需提交公司股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.